(Press-News.org) SAN FRANCISCO (February 10, 2011) — More than two thousand physicians, some of the top obstetric/gynecologists in the world who specialize in maternal-fetal medicine, especially high risk pregnancies, gathered today for their annual meeting in San Francisco to begin four days of intensive research presentations. Presentations each year at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting ™, represent major findings in reducing high-risk pregnancies and complications.
Catherine Y. Spong, M.D., chief, pregnancy and perinatology branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, discussed the government study that she co-authored, "Management of Myelomeningocele Study" (MOMS) at the SMFM annual meeting. An article on the study appeared today in the New England Journal of Medicine.
Myelomeningocele is the most serious form of spina bifida, a condition in which the spinal column fails to close around the spinal cord and the cord protrudes through an opening in the spine.
The $22.5 million study looked at the benefits of a surgical procedure used to repair this common defect of the spine while the baby is still in the uterus. The findings reported that the procedure greatly reduced the need to divert, or shunt, fluid away from the brain. The surgical procedure consists of closing an opening at the back of the fetal spine, which is a departure from the traditional approach of operating on the infant after birth.
The fetal procedure increases the chances that a child will be able to walk without crutches or other devices.
"This research is a huge finding for our profession and our patients," stated Joshua Copel, M.D., professor of Obstetrics, Gynecology and Reproductive Science at Yale University. Copel is also president of SMFM and a clinical practitioner in prenatal ultrasound and prenatal therapy.
The study cautioned that there were risks involved and that, because the surgery is highly specialized, it should only be undertaken in facilities with experienced staff. Infants who underwent the prenatal surgery were more likely to be born premature than were the infants who had the surgery performed after birth. Mothers who underwent the procedure were at risk of a thinning or tearing of the uterus at the incision. In spite of these risks though, children who underwent the prenatal surgery did much better than those who had the surgery after birth.
In fact, the MOMS study, which planned to enroll 200 expectant mothers carrying a child with myelomeningocele, was stopped after the enrollment of 183 women because of the benefits demonstrated in children who underwent the prenatal surgery.
The study was conducted in partnership with researchers at the Children's Hospital of Philadelphia (CHOP), The UCSF Benioff Children's Hospital at the University of California, San Francisco (UCSF), Vanderbilt University Medical Center in Nashville, and the George Washington University Biostatistics Center in Washington, D.C.
"This study is an indicator of the medical advancements being made in preventing high-risk pregnancies and complications," Copel added.
Some of the studies being presented at the SMFM annual meeting include research on:
The benefits of fetal heart rate monitoring in reducing infant mortality,
The increased risk of morbidity in babies delivered between 36 and 38 weeks,
The use of 30% less analgesia during labor when patients administer their own epidural analgesia,
Folate, which found that it does not offer preterm delivery protection,
The use of magnesium sulfate and how it may offer protection from cerebral palsy induced by magnesium sulfate,
The use of alcohol free antibacterial mouth-rinse associated with decreased incidence of preterm birth.
###
To see additional presentation abstracts and news releases, please go to www.smfm.org and visit the newsroom. To read the New England Journal of Medicine article, go to
http://www.nejm.org/doi/full/10.1056/NEJMoa1014379?query=featured_home .
The Society for Maternal-Fetal Medicine (est. 1977) is a non-profit membership group for obstetricians/gynecologists who have additional formal education and training in maternal-fetal medicine. The society is devoted to reducing high-risk pregnancy complications by providing continuing education to its 2,000 members on the latest pregnancy assessment and treatment methods. It also serves as an advocate for improving public policy, and expanding research funding and opportunities for maternal-fetal medicine. The group hosts an annual scientific meeting in which new ideas and research in the area of maternal-fetal medicine are unveiled and discussed. For more information, visit www.smfm.org.
SMFM highlights significance of spina bifida research findings
2011-02-14
ELSE PRESS RELEASES FROM THIS DATE:
SLU research implicates natural toxin as triggering Parkinson's disease
2011-02-14
ST. LOUIS – In new research from Saint Louis University, investigators have found evidence that a toxin produced by the brain is responsible for the series of cellular events that lead to Parkinson's disease. The study, published in PLoS One, found that the brain toxin DOPAL plays a key role in killing the dopamine neurons which trigger the illness.
In earlier research, Saint Louis University investigators found that DOPAL seemed to be responsible for killing healthy dopamine cells, which in turn causes Parkinson disease to develop. Now, research in an animal model ...
LED products billed as eco-friendly contain toxic metals, study finds
2011-02-14
Irvine, Calif., Feb. 10, 2011 – Those light-emitting diodes marketed as safe, environmentally preferable alternatives to traditional lightbulbs actually contain lead, arsenic and a dozen other potentially hazardous substances, according to newly published research.
"LEDs are touted as the next generation of lighting. But as we try to find better products that do not deplete energy resources or contribute to global warming, we have to be vigilant about the toxicity hazards of those marketed as replacements," said Oladele Ogunseitan, chair of UC Irvine's Department of Population ...
When nature calls
2011-02-14
COLLEGE STATION, Feb. 9, 2011 — When you've got to go, you've got to go — upstream, that is, if you are a male swordtail fish seeking a mate, according to research from Texas A&M University.
A recent study led by Texas A&M biologists Dr. Gil Rosenthal and Dr. Heidi Fisher in collaboration with scientists at Centro de Investigaciones Cientificas de las Huastecas in Hidalgo, Mexico, and Boston University has determined that the fish use chemical cues in their urine to elicit sexual responses from their downstream female counterparts.
In a study funded by the National ...
New model reveals pesticide-free method that takes a bite out of mosquito-borne disease
2011-02-14
Scientists have modeled a system that may be used to control mosquitoes and the diseases they transmit, without the use of pesticides. In the proposed system, mosquitoes are engineered to carry two genes. The first gene causes males to transmit a toxin to females through their semen. The second gene, when expressed in females, makes them immune to this toxin. This research, published in the February 2011 issue of Genetics (http://www.genetics.org), describes a system that can be created using currently available molecular tools and could confine the spread of mosquitoes ...
UCSB chemists make discovery that may lead to drug treatment possibilities for Alzheimer's
2011-02-14
(Santa Barbara, Calif.) –– UC Santa Barbara scientists have made a discovery that has the potential for use in the early diagnosis and eventual treatment of plaque-related diseases such as Alzheimer's disease and Type 2 diabetes. Their work is published in a recent issue of Nature Chemistry.
The amyloid diseases are characterized by plaque that aggregates into toxic agents that interact with cellular machinery, explained Michael T. Bowers, lead author and professor in the Department of Chemistry and Biochemistry. Other amyloid diseases include Parkinson's disease, Huntington's ...
Pulmonary fibrosis inhibited by pentraxin-2/SAP in research study
2011-02-14
MALVERN, PA – February 10, 2011 – Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today the publication of collaborative research in the International Journal of Biochemistry and Cell Biology entitled, "TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P." The research showed that human Pentraxin-2 (PTX-2), also called human Serum amyloid P (SAP), potently inhibits all undesirable pro-fibrotic pathologies driven by TGFβ1 and represents a novel ...
Chinks in the brain circuitry make some more vulnerable to anxiety
2011-02-14
Why do some people fret over the most trivial matters while others remain calm in the face of calamity? Researchers at the University of California, Berkeley, have identified two different chinks in our brain circuitry that explain why some of us are more prone to anxiety.
Their findings, published today (Thursday, Feb. 10) in the journal Neuron may pave the way for more targeted treatment of chronic fear and anxiety disorders. Such conditions affect at least 25 million Americans and include panic attacks, social phobias, obsessive-compulsive behavior and post-traumatic ...
Tumor microvesicles reveal detailed genetic information
2011-02-14
The Massachusetts General Hospital (MGH) research team that first discovered tumor-associated RNA in tiny membrane-enclosed sacs released into the bloodstream by cancer cells has now found that these microvesicles also contain segments of tumor DNA, including retrotransposons – also called "jumping genes" – that copy and insert themselves into other areas of the genome. The investigators' report, which has been published in Nature Communications, is the first to show that microvesicles are involved in transferring retrotransposons between cells.
"Retrotransposons' ...
UTHealth, Athersys preclinical research on stem cell therapy for stroke presented at AHA conference
2011-02-14
HOUSTON and LOS ANGELES – February 10th, 2011 – Medical researchers from The University of Texas Health Science Center at Houston (UTHealth) presented new research results at the American Heart Association International Stroke Conference that demonstrated how MultiStem®, a novel stem cell therapy being developed by Athersys, Inc. provided multiple benefits when administered in preclinical models of ischemic stroke. The study, conducted by leading researchers from the Department of Neurology at the UTHealth Medical School working in collaboration with scientists at Athersys, ...
Restructuring natural resource majors
2011-02-14
Madison, WI FEBRUARY 3, 2011 – A troublesome trend is occurring at colleges and universities around the country: fewer students are graduating with degrees in natural resource related degree programs. As a result, the number of qualified professionals to manage fish and wildlife programs is dwindling. What is even more troubling is that nationally, the percentage of students enrolling in the major has increased. For reasons unknown, students have been leaving the natural resource degree path after enrollment to pursue other degrees. Finding cause for the steady decline ...